Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-02-13-Speech-2-139"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2001-02-13"^^xsd:date2
dcterms:Is Part Of	lp_eu:Deliberate release of GMOs into the environment2
dcterms:Language	"it"^^xsd:language2
lpv:document identification number	"en.20010213.7.2-139"2
lpv:hasSubsequent	lp_eu:2001-02-13-Speech-2-1402
lpv:speaker	lp:Guido Sacconi2
lpv:spokenAs	substitute; Temporary committee on human genetics and other new technologies in modern medicine (2000-12-13--2001-11-29)3 member; Delegation to the EU-Turkey Joint Parliamentary Committee (1999-10-06--2002-01-14)3 substitute; Committee on Regional Policy, Transport and Tourism (1999-07-22--2002-01-14)3 unknown; Democratici di Sinistra (1999-07-20--2004-07-19)3 member; PES (1999-07-20--2004-07-19)3 substitute; PETI (1999-07-22--2002-01-14)3 vice-chair; Committee on the Environment, Public Health and Consumer Policy (2001-01-15--2002-01-14)3
lpv:translated text	"Mr President, after three long years, we are, at last, nearing the end of the process of revising Directive 90/220/EEC. Anyone who has watched the progress made, step by step, towards this goal, as I have, cannot fail to agree that we are providing the European Union with legislation on genetically modified organisms which, in addition to improving upon the previous legislation, also places us at the forefront on an international level. Just one example is the procedures for granting authorisations, particularly in terms of transparency and accessibility to the public, which is an essential condition for the necessary research trials to be able to proceed in a favourable climate. Further examples are the assessment and monitoring of the cumulative effects on the environment, and the phasing out of antibiotic-resistant marker genes. The lion's share of the praise for this progress must certainly go to our rapporteur, Mr David Bowe, who has succeeded in combining decisiveness with flexibility. It is certainly the fault of the Commission, rather than Mr Bowe, if we are still labouring under the burden of being unable, at present, to adopt flanking legislation on the tracing and labelling of GMOs and GMO derivatives placed on the market and thereby present the consumer with a complete framework of certainties. The undertaking, confirmed yesterday in a letter from the Commission to the Members of the parliamentary delegation, is important in political terms but does not entirely make up for the delays in preparing a clear, well-defined proposal. For these reasons, I am convinced that we should endorse the conclusions of the conciliation procedure, but with one explicit reservation: the moratorium on commercial approvals must remain in place until the gap has been filled."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph